PHARMATHENE INC's ticker is PIP and the CUSIP is 71714G102. A total of 49 filers reported holding PHARMATHENE INC in Q2 2016. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $1,091,000 | -31.8% | 1,344,728 | +173.3% | 0.00% | -100.0% |
Q4 2016 | $1,599,000 | +45.4% | 492,018 | +29.7% | 0.00% | 0.0% |
Q3 2016 | $1,100,000 | +20.2% | 379,336 | +1.1% | 0.00% | – |
Q2 2016 | $915,000 | +61.7% | 375,376 | +25.3% | 0.00% | – |
Q1 2016 | $566,000 | -0.5% | 299,534 | 0.0% | 0.00% | – |
Q4 2015 | $569,000 | +43.0% | 299,534 | 0.0% | 0.00% | – |
Q3 2015 | $398,000 | +1.5% | 299,534 | +37.2% | 0.00% | – |
Q2 2015 | $392,000 | +10.4% | 218,299 | 0.0% | 0.00% | – |
Q1 2015 | $355,000 | -10.1% | 218,299 | 0.0% | 0.00% | – |
Q4 2014 | $395,000 | +1.8% | 218,299 | 0.0% | 0.00% | – |
Q3 2014 | $388,000 | +58.4% | 218,299 | +25.2% | 0.00% | – |
Q2 2014 | $245,000 | -23.2% | 174,428 | 0.0% | 0.00% | – |
Q1 2014 | $319,000 | -1.5% | 174,428 | 0.0% | 0.00% | – |
Q4 2013 | $324,000 | -11.5% | 174,428 | 0.0% | 0.00% | – |
Q3 2013 | $366,000 | +62.7% | 174,428 | +23.0% | 0.00% | – |
Q2 2013 | $225,000 | – | 141,816 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PERKINS CAPITAL MANAGEMENT INC | 520,000 | $422,000 | 0.44% |
FIRST QUADRANT LLC/CA | 1,655,539 | $1,343,000 | 0.03% |
OXFORD ASSET MANAGEMENT LLP | 1,118,005 | $907,000 | 0.02% |
CIGNA INVESTMENTS INC /NEW | 303,239 | $246,000 | 0.02% |
Burt Wealth Advisors | 17,870 | $15,000 | 0.01% |
Sullivan, Bruyette, Speros & Blaney, LLC | 126,346 | $103,000 | 0.01% |
ClariVest Asset Management LLC | 322,970 | $262,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 594,444 | $482,000 | 0.01% |
Renaissance Technologies | 4,790,931 | $3,888,000 | 0.01% |
Mraz, Amerine & Associates, Inc. | 20,000 | $15,000 | 0.01% |